Sequences for targeting metastatic cells
CA 2308565 A1 · Owner: Baylor College Of Medicine · Inventors: Thompson, Timothy C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods for the diagnosis evaluation and , treatment of metastatic diseases using metastatic sequences such as caveolin, to target metastatic cells. According to the methods of the present invention certain cancers, including metastatic prostate cancer may be treated by , therapies which suppress expression of the caveolin gene. The present invention relates to biological technologies designed to block the activity of caveolin or the function of caveolae, including vector delivery of antisense caveolin sequences, the use of anti-caveolin antibodies the use of promoters, and other approaches targeting the expression of caveolin.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 5, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 5, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 5, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.